Theodore Kelbel is a Rheumatology/Immunology physician affiliated with Orthopaedic Associates of Michigan. OpenAlex indexes 39 publications with 287 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3271 Clear Vista Ct NE
Grand Rapids, MI 495259477
Telephone
616-267-7125Provider last certified this registry record 24 Feb 2021.
Industry payments
44 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year202564 payments$44,787openpaymentsdata.cms.gov ↗
- Genentech USA, Inc.Program year202541 payments$28,426openpaymentsdata.cms.gov ↗
- Ionis Pharmaceuticals, Inc.Program year202529 payments$23,336openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
57%Leukotriene Receptor Antagonist23.6%Montelukast Sodium100%Part D≥12 patientsCorticosteroid15.6%Trelegy Ellipta62%Fluticasone Propionate38%Part D<11 patients+ 2 more classes in this area
Blood & clotting
21.9%Plasma Kallikrein Inhibitor16%Takhzyro100%Part D<11 patientsBradykinin B2 Receptor Antagonist5.9%Icatibant100%Part D<11 patientsMetabolism & gastrointestinal
16.5%H2 blocker11.8%Famotidine100%Part D<11 patientsCorticosteroid4.6%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Assessing Safety and Tolerability in Bee Venom Immunotherapy: Conventional vs. 1-day Ultra Rush Protocol
Journal of Allergy and Clinical Immunology
2025 - SURVEY OF PATIENTS WHO WERE PRESCRIBED EPINEPHRINE NASAL SPRAY
Annals of Allergy Asthma & Immunology
2025 - HEREDITARY ANGIOEDEMA WITH NORMAL C1 INHIBITOR SECONDARY TO PLASMINOGEN GENE DEFECT PRESENTING WITH LARYNGEAL ANGIOEDEMA
Annals of Allergy Asthma & Immunology
2024 - Venom component testing in the allergist office: a description of 27 North American patients
Journal of Allergy and Clinical Immunology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
William Merhi, DO
Orthopaedic Associates of Michigan
Jiangyong Min, MD
Orthopaedic Associates of Michigan
Mathew Chung, MD
Orthopaedic Associates of Michigan
Andre Gauri, MD
Orthopaedic Associates of Michigan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”